Recent Finacing
Recent Raise
AeroRx Therapeutics is a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic respiratory diseases, led by its inhaled LABA/LAMA candidate AERO-007 for COPD.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at AeroRx Therapeutics.
